Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CELCthis companyCelcuity Inc.	$70.06	-26.39×	52.11×	0×	-32.99×	-101.0%	0.0%	0.0%	0.0%	-176.1%	-40.8%	-2.9%	1.94×	-0.19×	-10.04×	10.55×	0.0%	2	1.62	2	C
ADPTAdaptive Biotechnologies Corporation	$30.29	-41.64×	11.26×	8.9×	-89.6×	-203.3%	74.2%	-20.6%	-21.5%	-27.2%	-13.1%	-2.0%	1.28×	-7.04×	-4.85×	3.34×	0.0%	4	2.73	1	D+
BLLNBillionToOne, Inc.	$113.27	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
CSTLCastle Biosciences, Inc.	$33.23	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
NEONeoGenomics, Inc.	$17.33	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
PSNLPersonalis, Inc.	$15.96	-8.75×	2.72×	10.2×	-8.82×	-125.4%	22.7%	-126.4%	-116.7%	-31.1%	-29.1%	-11.2%	0.15×	1.19×	-429.55×	6.76×	0.0%	1	9.87	1	C-
Peer median	—	-14×	2.72×	8.9×	-8.82×	-168.7%	68.3%	-12.4%	-14.9%	-12.9%	-6.8%	-1.4%	0.23×	-7.04×	-17.61×	5.26×	0.0%	4	7.56	1	—